tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Mouth Diseases D009059 5 associated lipids
Meningococcal Infections D008589 3 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Sarcoidosis D012507 13 associated lipids
Hepatolenticular Degeneration D006527 3 associated lipids
Hyperglycemia D006943 21 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Inflammatory Bowel Diseases D015212 9 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Fatty Liver D005234 48 associated lipids
Cataract D002386 34 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Postoperative Complications D011183 5 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Heart Failure D006333 36 associated lipids
Angioedema D000799 6 associated lipids
Fractures, Spontaneous D005598 4 associated lipids
Hydronephrosis D006869 4 associated lipids
Trypanosomiasis D014352 5 associated lipids
Alopecia D000505 14 associated lipids
Liver Diseases D008107 31 associated lipids
Corneal Diseases D003316 13 associated lipids
Testicular Diseases D013733 15 associated lipids
Facial Dermatoses D005148 7 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Acne Vulgaris D000152 35 associated lipids
Urination Disorders D014555 9 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Anemia, Hemolytic D000743 4 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Vision Disorders D014786 10 associated lipids
Multiple Myeloma D009101 13 associated lipids
Osteochondrodysplasias D010009 3 associated lipids
Melanoma D008545 69 associated lipids
Hematologic Diseases D006402 3 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Osteoporosis D010024 12 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Kidney Diseases D007674 29 associated lipids
Hematuria D006417 13 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Infection D007239 6 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Bone Diseases D001847 4 associated lipids
Leukemia P388 D007941 43 associated lipids
Ulcer D014456 16 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Obesity D009765 29 associated lipids
Thrombosis D013927 49 associated lipids
Bradycardia D001919 13 associated lipids
Hemorrhage D006470 15 associated lipids
Proteinuria D011507 30 associated lipids
Lymphoma D008223 18 associated lipids
Femur Head Necrosis D005271 5 associated lipids
Alzheimer Disease D000544 76 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Eye Diseases D005128 12 associated lipids
Arteriosclerosis D001161 86 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Dickerson JA et al. Tacrolimus and sirolimus in capillary dried blood spots allows for remote monitoring. 2015 Pediatr Transplant pmid:25414084
Jahan A et al. Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome. 2015 Pediatr. Nephrol. pmid:26135137
Marquezan MC et al. Effect of Topical Tacrolimus in the Treatment of Thygeson's Superficial Punctate Keratitis. 2015 Am. J. Ophthalmol. pmid:26133248
Izumi Y et al. Two cases of refractory polymyositis accompanied with steroid myopathy. 2015 Mod Rheumatol pmid:24533547
Li H et al. Resistance reversal induced by a combination of fluconazole and tacrolimus (FK506) in Candida glabrata. 2015 J. Med. Microbiol. pmid:25355935
Gallon L et al. Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus. 2015 Kidney Int. pmid:25354238
Pamuk F et al. Evaluation of gingival alterations in rats medicated with cyclosporine A, tacrolimus and sirolimus: a stereological study. 2015 J. Periodont. Res. pmid:25399832
Huang X and Xu B Efficacy and Safety of Tacrolimus versus Pimecrolimus for the Treatment of Atopic Dermatitis in Children: A Network Meta-Analysis. 2015 Dermatology (Basel) pmid:26043855
Xia Z et al. Refractory Dyslipidemia After Liver Transplant: Case Study With Successive Histologic Investigations. 2015 Exp Clin Transplant pmid:25924105
Zheng L et al. Simultaneous determination of cortisol, cortisone, 6β-hydroxycortisol and 6β-hydroxycortisone by HPLC. 2015 J Chromatogr Sci pmid:25628347
Takahashi N et al. Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use. 2015 Rheumatol. Int. pmid:25991396
Gupta G et al. Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction. 2015 Am. J. Transplant. pmid:25988397
Brännström M et al. Livebirth after uterus transplantation. 2015 Lancet pmid:25301505
de Weerd AE et al. ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption. 2015 Transpl. Int. pmid:25070762
Yahng SA et al. A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia. 2015 Biol. Blood Marrow Transplant. pmid:25300871
Lin YK et al. Using Imiquimod-Induced Psoriasis-Like Skin as a Model to Measure the Skin Penetration of Anti-Psoriatic Drugs. 2015 PLoS ONE pmid:26355594
Andrews LM et al. Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients. 2015 Expert Opin Drug Metab Toxicol pmid:25865963
Matas AJ and Gaston RS Moving Beyond Minimization Trials in Kidney Transplantation. 2015 J. Am. Soc. Nephrol. pmid:25925686
Bogéa TH et al. Light Induces Ultrastructural Changes in Rod Outer and Inner Segments, Including Autophagy, in a Transgenic Xenopus laevis P23H Rhodopsin Model of Retinitis Pigmentosa. 2015 Invest. Ophthalmol. Vis. Sci. pmid:26720441
Hiraoka S et al. The earliest trough concentration predicts the dose of tacrolimus required for remission induction therapy in ulcerative colitis patients. 2015 BMC Gastroenterol pmid:25925267
Cuervas-Mons V et al. Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients. 2015 Clin Transplant pmid:25924549
Ramachandran R et al. Chronic nephrotoxicity limits successful use of Tacrolimus in the management of adult steroid-dependent minimal change disease. 2015 Nephrology (Carlton) pmid:25872662
Shahraki M et al. Influence of Tacrolimus (FK506) on Nerve Regeneration Using Allografts: A Rat Sciatic Nerve Model. 2015 J. Oral Maxillofac. Surg. pmid:25869987
Zhu L et al. Effects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients. 2015 Xenobiotica pmid:25869250
Jiang H et al. An acyltransferase domain of FK506 polyketide synthase recognizing both an acyl carrier protein and coenzyme A as acyl donors to transfer allylmalonyl and ethylmalonyl units. 2015 FEBS J. pmid:25865045
Dastgheib L et al. Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial. 2015 J Dermatolog Treat pmid:24552352
Rodríguez-Rodríguez AE et al. Glucose homeostasis changes and pancreatic β-cell proliferation after switching to cyclosporin in tacrolimus-induced diabetes mellitus. 2015 Nefrologia pmid:26299169
Halvorsen JA and Aasebø W Oral tacrolimus treatment of pruritus in prurigo nodularis. 2015 Acta Derm. Venereol. pmid:25804254
Sigurgeirsson B et al. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial. 2015 Pediatrics pmid:25802354
Kurita T et al. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis. 2015 Lupus pmid:25297551
Birdwell KA et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. 2015 Clin. Pharmacol. Ther. pmid:25801146
Shokati T et al. Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS. 2015 J Vis Exp pmid:26575262
Jo GA et al. Isolation and characterization of a 17-kDa FKBP-type peptidyl-prolyl cis/trans isomerase from Vibrio anguillarum. 2015 Protein Expr. Purif. pmid:25747528
Liu J et al. Adherence to Immunosuppressive Medication in Renal Transplant Recipients From Follow-up Outpatient in China: Association of 2 Different Measurement Methods. 2015 Clin Ther pmid:26519232
Guerra Júnior AA et al. Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil. 2015 Rev Saude Publica pmid:25741648
Youbin Z et al. Tumor Necrosis Factor-α-Induced Protein 8-Like 2 Gene Overexpression Prolongs the Survival of Rat Allogeneic Heart Allografts. 2015 Transplant. Proc. pmid:26518962
Schwarz C et al. Tacrolimus, Mycophenolate Mofetil, and Low-Dose Steroids With or Without Interleukin-2 Receptor Antibody Induction Therapy: A Retrospective Cohort Analysis. 2015 Transplant. Proc. pmid:26518948
Ko MS et al. Tacrolimus therapy causes hepatotoxicity in patients with a history of liver disease. 2015 Int J Clin Pharmacol Ther pmid:25740263
Cotton D Celebrating the ACP centennial: from the Annals archive. 2015 Ann. Intern. Med. pmid:25560715
Ikeya K et al. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis. 2015 Dig Liver Dis pmid:25682993
Zhao L et al. Bovine serum albumin nanoparticles for delivery of tacrolimus to reduce its kidney uptake and functional nephrotoxicity. 2015 Int J Pharm pmid:25681723
Ramesh M et al. A novel phosphatidic acid-protein-tyrosine phosphatase D2 axis is essential for ERBB2 signaling in mammary epithelial cells. 2015 J. Biol. Chem. pmid:25681440
Pascher A et al. Protein kinase C inhibitor sotrastaurin in de novo liver transplant recipients: a randomized phase II trial. 2015 Am. J. Transplant. pmid:25677074
Kim S et al. Reduction of increased calcineurin activity rescues impaired homeostatic synaptic plasticity in presenilin 1 M146V mutant. 2015 Neurobiol. Aging pmid:26455952
Fukuta T et al. Treatment of stroke with liposomal neuroprotective agents under cerebral ischemia conditions. 2015 Eur J Pharm Biopharm pmid:26455340
Buendía JA et al. Combinational Effect of CYP3A5 and MDR-1 Polymorphisms on Tacrolimus Pharmacokinetics in Liver Transplant Patients. 2015 Exp Clin Transplant pmid:26450467
Ceberio I et al. Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant. 2015 Leuk. Lymphoma pmid:24913499
Chung H et al. Renal transplantation: better fat than thin. 2015 J. Surg. Res. pmid:25634827
Pennington CA and Park JM Sublingual tacrolimus as an alternative to oral administration for solid organ transplant recipients. 2015 Am J Health Syst Pharm pmid:25631834
Satake K et al. Olopatadine hydrochloride suppresses hot flashes induced by topical treatment with tacrolimus ointment in rats. 2015 Eur. J. Pharmacol. pmid:26362749
Farhangian ME et al. Treatment of Alopecia Areata in the United States: A Retrospective Cross-Sectional Study. 2015 J Drugs Dermatol pmid:26355621
Kawahara T et al. The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion. 2015 Prostate pmid:25631176
Iwamoto T et al. Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of Voriconazole on Blood Tacrolimus Concentration in Patients Receiving Hematopoietic Stem Cell Transplantation. 2015 Ther Drug Monit pmid:25565672
Yao X et al. Limited Sampling Strategy for Mycophenolic Acid in Chinese Kidney Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus During the Early Posttransplantation Phase. 2015 Ther Drug Monit pmid:25565669
Lemaitre F et al. Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells. 2015 Clin. Biochem. pmid:25562187
Palanisamy AP et al. Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients. 2015 Clin Transplant pmid:25557762
Tedesco-Silva H et al. Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses. 2015 Am. J. Transplant. pmid:25988935
Lu YX et al. A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients. 2015 Acta Pharmacol. Sin. pmid:25500866
Zhang JJ et al. The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients. 2015 Int J Clin Pharmacol Ther pmid:26227094
Jung JW et al. Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease. 2015 Am. J. Ophthalmol. pmid:25498356
Roberts WK et al. A destructive feedback loop mediated by CXCL10 in central nervous system inflammatory disease. 2015 Ann. Neurol. pmid:26224283
Denardi LB et al. Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates. 2015 Braz. J. Microbiol. pmid:26221097
Kloster-Jensen K et al. Intracellular sirolimus concentration is reduced by tacrolimus in human pancreatic islets in vitro. 2015 Transpl. Int. pmid:26046470
Koster RA et al. The performance of five different dried blood spot cards for the analysis of six immunosuppressants. 2015 Bioanalysis pmid:26045003
Georgakopoulou EA and Scully C Systemic use of non-biologic agents in orofacial diseases: other immunomodulatory agents. 2015 Oral Dis pmid:24028818
Peake RW et al. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry. 2015 Ther Drug Monit pmid:25072947
Lancia P et al. Choosing the right dose of tacrolimus. 2015 Arch. Dis. Child. pmid:25416736
Kabrine M and Laraba-Djebari F Immunomodulatory and protective properties of tacrolimus in experimental scorpion envenomation. 2014 Jan-Mar Int J Immunopathol Pharmacol pmid:24674680
Wang C and Lin A Efficacy of topical calcineurin inhibitors in psoriasis. 2014 Jan-Feb J Cutan Med Surg pmid:24377467
Feito-Rodríguez M et al. Bacterial vaginosis in the context of lichen sclerosus in a prepubertal girl. 2014 Jan-Feb Pediatr Dermatol pmid:24125016
Veisa G et al. The importance of renal biopsy in the management of renal transplantation. 2014 Apr-Jun Rev Med Chir Soc Med Nat Iasi pmid:25076703
Grinyó JM and Petruzzelli S Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations. 2014 Expert Rev Clin Immunol pmid:25407098
Uchida J et al. Effects of conversion from a twice-daily tacrolimus to a once-daily tacrolimus on glucose metabolism in stable kidney transplant recipients. 2014 Transplant. Proc. pmid:24656005
Zaltzman JS et al. A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteers. 2014 Transpl. Int. pmid:25160518
Gérard C et al. Determination of the most influential sources of variability in tacrolimus trough blood concentrations in adult liver transplant recipients: a bottom-up approach. 2014 AAPS J pmid:24526611
Mocchegiani F et al. Tacrolimus and Everolimus de novo versus minimization of standard dosage of Tacrolimus provides a similar renal function at one year after liver transplantation: a case-control matched-pairs analysis. 2014 Ann. Transplant. pmid:25347718
Méndez A et al. Pharmacokinetic study of conversion from tacrolimus twice-daily to tacrolimus once-daily in stable lung transplantation. 2014 Transplantation pmid:24492423
Moss MC et al. Lithium use for bipolar disorder post renal transplant: is mood stabilization without toxicity possible? 2014 Transplantation pmid:24492429
Hinchliffe E et al. Therapeutic drug monitoring of ciclosporin A and tacrolimus in heart lung transplant patients using dried blood spots. 2014 Ann. Clin. Biochem. pmid:23939194
Isoda K et al. The proton pump inhibitor lansoprazole, but not rabeprazole, the increased blood concentrations of calcineurin inhibitors in Japanese patients with connective tissue diseases. 2014 Intern. Med. pmid:24990333
Buendia JA et al. Effects of combinational CYP3A5 6986A>G polymorphism in graft liver and native intestine on the pharmacokinetics of tacrolimus in liver transplant patients: a meta-analysis. 2014 Ther Drug Monit pmid:24378577
Eid L et al. Late acute rejection: incidence, risk factors, and effect on graft survival and function. 2014 Pediatr Transplant pmid:24372967
Basu B Ofatumumab for rituximab-resistant nephrotic syndrome. 2014 N. Engl. J. Med. pmid:24670185
Fukushima A et al. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement. 2014 Br J Ophthalmol pmid:24695688
Schellekens J et al. The Maastricht Transplant Center: clinical setting and epitope searches in HLA class II molecules: does the structural localization of a polymorphic site contribute to its immunogenicity? 2014 Transpl. Immunol. pmid:25240735
Parks AC et al. Long-term clearance of linear porokeratosis with tacrolimus, 0.1%, ointment. 2014 JAMA Dermatol pmid:24553841
Xu C et al. Tacrolimus reversibly reduces insulin secretion, induces insulin resistance, and causes islet cell damage in rats. 2014 Int J Clin Pharmacol Ther pmid:24755137
Caraveo G et al. Calcineurin determines toxic versus beneficial responses to α-synuclein. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25122673
Gajanayake T et al. A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft. 2014 Sci Transl Med pmid:25122638
García-García B et al. Frosch' surface microscopy score for the assessment of steroid-induced atrophy. 2014 Arch. Dermatol. Res. pmid:24402286
Marits P et al. Evaluation of T and B lymphocyte function in clinical practice using a flow cytometry based proliferation assay. 2014 Clin. Immunol. pmid:24909732
Uesugi M et al. Impact of cytochrome P450 3A5 polymorphism in graft livers on the frequency of acute cellular rejection in living-donor liver transplantation. 2014 Pharmacogenet. Genomics pmid:24911663
Al-Harbi NO et al. Olmesartan attenuates tacrolimus-induced biochemical and ultrastructural changes in rat kidney tissue. 2014 Biomed Res Int pmid:24987695
Saracino A et al. Multidrug-resistance 1 gene single-nucleotide polymorphisms do not influence long-term graft survival after kidney transplantation. 2014 Transplant. Proc. pmid:25242754
Zhu H et al. Tacrolimus promotes hepatocellular carcinoma and enhances CXCR4/SDF‑1α expression in vivo. 2014 Mol Med Rep pmid:24912495
Van Laecke S et al. The effect of magnesium supplements on early post-transplantation glucose metabolism: a randomized controlled trial. 2014 Transpl. Int. pmid:24909487
Trkulja V et al. Effect of cyclosporine on steady-state pharmacokinetics of MPA in renal transplant recipients is not affected by the MPA formulation: analysis based on therapeutic drug monitoring data. 2014 Ther Drug Monit pmid:24518562
Sánchez L et al. Topical tacrolimus for recurrent penile Crohn's disease. 2014 J Crohns Colitis pmid:24815787
Wang J and Fan H [Assessment of P70S6 kinase phosphorylation after liver transplantation by phospho-flow cytometry]. 2014 Zhonghua Yi Xue Za Zhi pmid:25623311
Hsiao FY and Hsu WW Epidemiology of post-transplant malignancy in Asian renal transplant recipients: a population-based study. 2014 Int Urol Nephrol pmid:24009082